Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Microcrystalline Cellulose Market size was estimated at USD 1.26 billion in 2024 and is expected to surpass USD 2.86 billion by the end of 2037, rising at a CAGR of 6.9% during the forecast period, i.e., 2025-2037. In 2025, the industry size of microcrystalline cellulose is estimated at USD 1.35 billion.
Pharmaceuticals continue to be the largest sector worldwide supporting microcrystalline cellulose (MCC) usage, comprising around 46% of total worldwide usage in 2024. The primary demand is attributed to the use of MCC as a crucial excipient in non-hydrated solid dose medicinal formulations, especially tablets. As stated by the U.S. Food and Drug Administration (FDA), 71% of oral solid drugs utilize MCC as an excipient, and its incorporation into generic and over-the-counter (OTC) medicines is increasing.
The World Health Organization (WHO) indicates that generic drug manufacturing is growing at 5.3% annually, especially in markets like India and China. Regulatory regimes responsible for product approval, i.e., FDA Quality-by-Design (QbD) and sustainability, by ensuring that products have a reliable and stable shelf life, which can also help regulate dissolution efficiency, are all aligned to employ MCC as an excipient. Also, the European Medicines Agency (EMA) reported a 13% increase in MCC-based Medicines Authorizations from 2020 to 2024, with most of the reported increase coming from the continued applications for new medicines to launch controlled-release medicines.
 Market Size.webp)
